Literature DB >> 4558479

Relations between immunity and malignancy.

R A Good.   

Abstract

A higher incidence of malignancy as well as greater susceptibility to infection has been found to be associated with primary immunodeficiencies. An increased incidence of leukemia has been associated with X-linked infantile agammaglobulinemia-an isolated defect of humoral immunities. An increased frequency of a wide variety of malignancies have been found to accompany several different forms of primary immunodeficiency. Secondary immunodeficiencies produced by immunosuppressant therapy to facilitate renal transplantation have also been found to have far too much cancer to be explained by chance assocaition. Many experimental associations between immunity and malignancy have also been encountered, indicating that these two adaptive processes have an essential relationship that must be elucidated.

Entities:  

Mesh:

Year:  1972        PMID: 4558479      PMCID: PMC426620          DOI: 10.1073/pnas.69.4.1026

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

Review 1.  The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.

Authors:  I M Svane; M Boesen; A M Engel
Journal:  Med Oncol       Date:  1999-12       Impact factor: 3.064

Review 2.  Recent studies on the immunodeficiencies of man.

Authors:  R A Good
Journal:  Am J Pathol       Date:  1972-12       Impact factor: 4.307

3.  Skin transplantation in the study of chemical carcinogenesis. II. Iso- and autografting of skin from mice intragastrically initiated with 9,10-dimethyl-1,2 benzanthracene with and without subsequent application of the promoting agent TPA.

Authors:  P K Worst; R Bauz
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

4.  Differential effects of the mottled yellow and pseudoagouti phenotypes on immunocompetence in Avy/a mice.

Authors:  D W Roberts; G L Wolff; W L Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  A peripheral blood biomarker estimates probability of survival: the neutrophil-lymphocyte ratio in noncancer patients.

Authors:  Jeremy L Davis; Vitor Moutinho; Katherine S Panageas; Daniel G Coit
Journal:  Biomark Med       Date:  2016-08-18       Impact factor: 2.851

6.  Suppression of cell-mediated immunity after infection with attenuated rubella virus.

Authors:  R Ganguly; C L Cusumano; R H Waldman
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

7.  Suppression of tuberculin hypersensitivity during influenza infection in mice.

Authors:  R M Massanari
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

8.  Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.

Authors:  Y Umeda; A Sakamoto; J Nakamura; H Ishitsuka; Y Yagi
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

Review 9.  Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature.

Authors:  C Sirinavin; A A Trowbridge
Journal:  J Med Genet       Date:  1975-12       Impact factor: 6.318

Review 10.  Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.

Authors:  Jesus I Luna; Steven K Grossenbacher; William J Murphy; Robert J Canter
Journal:  Expert Opin Biol Ther       Date:  2016-12-23       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.